Patent · US Active

Recombinant glycoproteins with reduced antennary fucosylation

US11193156B2 · kind B2 · utility

0Cited by

2References

15Claims

0Family size

Assignee

CEVEC Pharmaceuticals GmbH · DE

Inventors

Hanns-Martin Schmidt · Cologne, DE
Markus Ribbert · Biberach an der Riß, DE
Gudrun Schiedner · Cologne, DE
Silke Wissing · Cologne, DE
Jens Wölfel · Langenfeld, DE

Key dates

Filing date	Mar 15, 2018
Grant date	Dec 7, 2021
Priority date	—
Expiry date	Mar 15, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y204/99004
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to methods for reducing antennary fucosylation of complex N-glycans in recombinantly expressed glycoproteins, cell lines that can be used in said methods, respective recombinant glycoproteins, and methods for expressing the same in said cell lines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.